Lipton, R. B., Rosen, N. L., Ailani, J., DeGryse, R. E., Gillard, P. J., & Varon, S. F. (2016). OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine over one year of treatment: Pooled results from the PREEMPT randomized clinical trial program. Cephalalgia.
シカゴスタイル引用形Lipton, Richard B., Noah L. Rosen, Jessica Ailani, Ronald E. DeGryse, Patrick J. Gillard, , Sepideh F. Varon. "OnabotulinumtoxinA Improves Quality of Life and Reduces Impact of Chronic Migraine Over One Year of Treatment: Pooled Results From the PREEMPT Randomized Clinical Trial Program." Cephalalgia 2016.
MLA引用形式Lipton, Richard B., et al. "OnabotulinumtoxinA Improves Quality of Life and Reduces Impact of Chronic Migraine Over One Year of Treatment: Pooled Results From the PREEMPT Randomized Clinical Trial Program." Cephalalgia 2016.